SCHEMBL15528952

SCHEMBL15528952

O=C(CC1CC1)N1CCC(Oc2ccc(NC(=O)N3CC(c4cccnc4)C3)cc2)C1

nearest known ligand 0.70

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 20/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15528947 1.00 NAMPT (0.70) NAMPT
SCHEMBL15529066 1.00 NAMPT (0.70) NAMPT
SCHEMBL15529328 0.97 NAMPT (0.72) NAMPT
SCHEMBL15529607 0.97 NAMPT (0.72) NAMPT
SCHEMBL15528953 0.97 NAMPT (0.71) NAMPT
SCHEMBL15528956 0.97 NAMPT (0.71) NAMPT
SCHEMBL15529950 0.96 NAMPT (0.68) NAMPT
SCHEMBL15529354 0.94 NAMPT (0.68) NAMPT
SCHEMBL15529357 0.94 NAMPT (0.68) NAMPT
SCHEMBL15528984 0.94 NAMPT (0.68) NAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2852585-A1 NAMPT INHIBITORS AbbVie Inc. (US) 2015-04-01 EP claimed
WO-2013170113-A1 NAMPT INHIBITORS ABBVIE INC. (US) 2013-11-14 WO claimed
EP-2852585-A1 NAMPT INHIBITORS AbbVie Inc. (US) 2015-04-01 EP disclosed
WO-2013170113-A1 NAMPT INHIBITORS ABBVIE INC. (US) 2013-11-14 WO disclosed